JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (5): 72-78.doi: 10.6040/j.issn.1673-3770.0.2017.297

Previous Articles     Next Articles

Investigation of chemosensitization induced by nitric oxide on nasopharyngeal carcinoma CNE-2 cells.

ZHANG Caixia1,2, LIU Yangyun1, JIANG Wen1, LIU Gengxun1, CAO Hang1, CHEN Qiong1, ZHANG Jishuai1   

  1. Department of Otolaryngology, 1. No.163 Hospital of PLA /The Second Affiliated Hospital of Hunan Normal University Medical College, Changsha 410003, Hunan, China;2. Liuzhou Workers Hospital / Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou 545000, Guangxi, China
  • Received:2017-07-07 Online:2017-10-16 Published:2017-10-16

PDF (PC)

495

Abstract: Objective To investigate whether exogenous nitric oxide(NO)could increase chemosensitization to cisplatin(DDP)in CNE2 cells, and to provide an experimental and theoretical basis for improving the effectiveness of chemotherapy for nasopharyngeal carcinoma. Methods CNE-2 cells were treated with various concentrations of sodium nitroprusside(SNP), DDP, and both chemicals. The nitrate reductase method was used to detect the concentration of NO. Morphological changes of cells were observed using an inverted phase contrast microscope and CCK8 assays were used to examine the viability of cells. Flow cytometry was applied to detect apoptosis in NPC cells. Results (1)The concentration of NO was positively correlated with the concentration of SNP, and this correlation was statistically significant(r=0.968, P<0.05).(2)Compared with the CNE-2 cells in the SNP group, DDP group, and control group, the CNE-2 cells in the DDP+SNP group showed more extensive morphological changes.(3)The inhibitory effects of SNP+DDP were significantly greater than those of SNP or DDP alone(P<0.05).(4)Compared with the groups treated with SNP or DDP individually, flow cytometry showed that the apoptosis rate of CNE-2 cells was significantly higher in the group treated with both SNP and DDP(P<0.05). Conclusion Exogenous NO can inhibit CNE-2 proliferation, and the inhibitory effect was positively correlated with the concentration of NO. The proper concentration of exogenous NO can significantly enhance the chemosensitivity of CNE-2 cells to DDP, without substantial toxicity.

Key words: Nasopharyngeal carcinoma, Sodium nitroprusside, Cis-platinum, Apoptosis, Chemosensitization, Nitric oxide

CLC Number: 

  • R739.62
[1] Tan G, Tang X, Tang F. The role of microRNAs in nasopharyngeal carcinoma[J]. Tumour Biol, 2015, 36(1):69-79.
[2] Razak AR, Siu LL, Liu FF, et al. Nasopharyngeal carcinoma: the next challenges[J]. Eur J Cancer, 2010, 46(11):1967-1978.
[3] Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer[J]. Semin Radiat Oncol, 2012, 22(3):233-244.
[4] Perri F, Bosso D, Buonerba C, et al. Locally advanced nasopharyngeal carcinoma: current and emerging treatment strategies[J]. World J Clin Oncol, 2011, 2(12):377-383.
[5] Zhang L, Chen QY, Liu H, et al. Emerging treatment options for nasopharyngeal carcinoma[J]. Drug Des Devel Ther, 2013, 7(2):37-52.
[6] 张彩霞, 刘阳云. 一氧化氮对肿瘤细胞化疗增敏机制研究进展[J]. 临床与病理杂志,2016,36(8):1224-1229. ZHANG Caixia, LIU Yangyun. Research progress of nitric oxide chemosensitization mechanisms on tumor cells[J]. Inter J Pathol Clin Med, 2013, 7(2):37-52.
[7] Yang L, Lan C, Fang Y, et al. Sodium nitroprusside(SNP)sensitizes human gastric cancer cells to TRAIL-induced apoptosis[J]. Int Immunopharmacol, 2013, 17(2):383-389.
[8] Seabra AB, de Lima R, Calderón M. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives[J]. Curr Top Med Chem, 2015, 15(4):298-308.
[9] Zhang HX, Deng C, Liu OS, et al. Inducible nitric oxide inhibitor enhances the anti-tumor effect of cisplatin on CNE-2 cells by inducing cell apoptosis[J]. Eur Rev Med Pharmacol Sci, 2014, 18(19):2789-2797.
[10] 刘阳云, 赵素萍, 刘庚勋, 等. 诱导型一氧化氮合酶在指导晚期鼻咽癌治疗方案选择中的价值[J]. 中国癌症杂志,2007,17(9):684-688. LIU Yangyun, ZHAO Suping, LIU Gengxun, et al. The value of inducible nitric oxide synthase to select the project of treatment in nasopharyngeal carcinoma[J]. Chin Oncol, 2007, 17(9):684-688.
[11] 刘阳云, 赵素萍, 刘庚勋, 等. 诱导型一氧化氮合酶与环氧合酶-2在鼻咽癌中表达的初步研究[J]. 中华放射肿瘤学杂志,2007,16(2):155-156.
[12] Mocellin S. Nitric oxide: cancer target or anticancer agent?[J]. Curr Cancer Drug Targets, 2009, 9(2):214-236.
[13] 张彩霞,刘阳云. 一氧化氮供体型化合物化疗增敏效应[J]. 国际肿瘤学杂志,2016,43(9):53-56. ZHANG Caixia, LIU Yangyun. Neoplasms chemosensitization enhancing effects of nitric oxide donor compounds[J]. J Int Oncol, 2016, 43(9):53-56.
[14] Hirst D, Robson T. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy[J]. Curr Pharm Des, 2010, 16(4):411-420.
[15] Carradori S, Mollica A, Monte CD, et al. Nitric oxide donors and selective carbonic anhydrase inhibitors: a dual pharmacological approach for the treatment of glaucoma, cancer and osteoporosis[J]. Molecules, 2015, 20(4):5667-5679.
[16] Reynolds MM, Witzeling SD, Damodaran VB, et al. Applications for nitric oxide in halting proliferation of tumor cells[J]. Biochem Biophys Res Commun, 2013, 4(31):647-651.
[17] Persson PB, Bondke Persson A. Nitric oxide: a classic revisited[J]. Acta Physiol, 2013, 207(3):427-429.
[18] Aranda E, López-Pedrera C, De La Haba-Rodriguez JR, et al. Nitric oxide and cancer: the emerging role of S-nitrosylation[J]. Curr Mol Med, 2012, 12(1):50-67.
[19] Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies[J]. Cancer Chemother Pharmacol, 2011, 67(6):1211-1224.
[20] González R1, Ferrín G, Aguilar-Melero P, et al. Targeting hepatoma using nitric oxide donor strategies[J]. Antioxid Redox Signal, 2013, 18(5):491-506.
[21] Huerta-Yepez S, Baritaki S, Baay-Guzman G, et al. Contribution of either YY1 or Bcl XL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer[J]. Nitric Oxide Soc, 2013, 29(1):17-24.
[22] Bian K, Murad F. sGC-cGMP signaling: target for anticancer therapy[J]. Adv Exp Med Biol, 2014, 14(8):5-13.
[23] Bian K, Murad F. What is next in nitric oxide research? From cardiovascularsystem to cancer biology[J]. Nitric Oxide, 2014, 4(3):3-7.
[24] Bonavida B, Garban H. Nitric oxide-mediated sensitization of resistant tumor cells to apoptosis by chemo-immunotherapeutics[J]. Redox Biol, 2015, 10(6):486-494.
[25] Sarti P, Forte E, Mastronicola D, et al. Cytochrome c oxidaseand nitric oxide in action: molecular mechanisms and pathophysiological implications[J]. Biochim Biophys Acta, 2012, 18(7):610-619.
[26] Bonavida B, Baritaki S. The novel role of yin yang 1 in the regulation of epithelial to mesenchymal transition in cancer via the dysregulated NF-κB/Snail/YY1/RKIP/PTEN circuitry[J]. Crit Rev Oncog, 2011, 16(4):211-226.
[27] Baritaki S, Huerta-Yepez S, Sahakyan A, et al. Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: inhibition of the metastasis-inducer snail and induction of the metastasis-suppressor RKIP[J]. Cell Cycle, 2010, 12(9):4931-4940.
[28] Tang H, Park S, Sun SC, et al. Kolcgnaling components of the IκB kinase complex[J]. FEBS Lett, 2010, 5(8):662-668.
[29] Domingo E, Church DN, Sieber O, et al. Evaluation of PIK3 CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer[J]. J Clin Oncol, 2013, 31(4):4297-4234.
[1] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[2] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[3] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[4] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[5] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[6] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[7] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[8] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[9] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[10] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[11] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
[12] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[13] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[14] ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76.
[15] ZHANG Jingyi, DONG Xiangyi, MU Yakui, SONG Xicheng. Research progress on pyroptosis in otorhinolaryngology diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 140-148.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd